Invex Therapeutics Company
Invex is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment.
Technology:
Drug Delivery
Industry:
PharmTech
Headquarters:
Subiaco, Western Australia, Australia
Founded Date:
2019
Employees Number:
1-10
Funding Status:
IPO
Register and Claim Ownership